InspireMD, Inc. (NSPR)

InspireMD Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.94	18.92	9.64	4.63	12
Short-Term Investments	45.27	15.72	29.38	13.17	22.04
Cash & Short-Term Investments	54.21	34.64	39.02	17.8	34.04
Cash Growth	56.51%	-11.24%	119.19%	-47.70%	169.20%
Accounts Receivable	2.17	1.57	1.8	1.03	1.22
Other Receivables	0.4	0.68	0.65	0.21	0.17
Total Trade Receivables	2.57	2.25	2.45	1.25	1.39
Inventory	3.4	2.57	2.11	1.62	1.14
Other Current Assets	1.3	1.06	0.58	0.66	0.52
Total Current Assets	61.47	40.52	44.16	21.33	37.09
Net Property, Plant & Equipment	6.34	4.73	2.53	2.47	1.71
Other Long-Term Assets	1.59	1.56	0.95	0.86	0.91
Total Assets	69.4	46.81	47.64	24.65	39.71
Accounts Payable	1.26	1.25	0.94	0.66	0.89
Accrued Expenses	9.46	6.42	5.08	4.41	3.45
Total Current Liabilities	10.71	7.68	6.02	5.07	4.35
Long-Term Leases	2.22	1.8	1.04	1.2	0.78
Other Long-Term Liabilities	1.27	1.25	1.08	1	1.05
Total Long-Term Liabilities	3.49	3.04	2.12	2.19	1.83
Total Liabilities	14.2	10.72	8.14	7.26	6.18
Common Stock	0	0	0	0	0
Additional Paid-in Capital	357.49	289.59	261	218.98	216.63
Retained Earnings	-302.29	-253.51	-221.5	-201.59	-183.09
Shareholders' Equity	55.2	36.09	39.5	17.39	33.53
Total Liabilities & Equity	69.4	46.81	47.64	24.65	39.71
Total Debt	2.22	1.8	1.04	1.2	0.78
Net Cash (Debt)	51.99	32.84	37.99	16.61	33.26
Net Cash Growth	58.30%	-13.54%	128.72%	-50.07%	185.58%
Net Cash Per Share	0.81	0.78	1.56	2.11	4.53
Book Value	55.2	36.09	39.5	17.39	33.53
Book Value Per Share	0.86	0.86	1.63	2.21	4.56
Tangible Book Value	55.2	36.09	39.5	17.39	33.53
Tangible Book Value Per Share	0.86	0.86	1.63	2.21	4.56

Updated Mar 18, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q